CENTAURUS FINANCIAL, INC. - STRONGBRIDGE BIOPHARMA PLC ownership

Quarter-by-quarter ownership
CENTAURUS FINANCIAL, INC. ownership history of STRONGBRIDGE BIOPHARMA PLC
ValueSharesWeighting
Q1 2021$101,000
+13.5%
36,5000.0%0.01%
+11.1%
Q4 2020$89,000
+58.9%
36,500
+37.7%
0.01%
+12.5%
Q3 2020$56,000
+47.4%
26,500
+165.0%
0.01%
+33.3%
Q2 2020$38,000
+100.0%
10,0000.0%0.01%
+50.0%
Q1 2020$19,000
-9.5%
10,0000.0%0.00%
+33.3%
Q4 2019$21,00010,0000.00%
Other shareholders
STRONGBRIDGE BIOPHARMA PLC shareholders Q3 2023
NameSharesValueWeighting ↓
CAXTON CORP 5,376,039$47,309,00051.34%
Lyon Street Capital, LLC 3,182,149$28,162,0009.07%
Opaleye Management Inc. 1,590,000$14,071,0004.02%
Broadfin Capital, LLC 2,793,752$24,725,0003.85%
Vivo Capital, LLC 1,918,132$16,975,0002.40%
ARMISTICE CAPITAL, LLC 3,372,000$29,842,0002.28%
PRECEPT MANAGEMENT LLC 470,000$4,160,0001.73%
NEA Management Company, LLC 4,141,308$36,651,0001.63%
Harvest Capital Strategies LLC 825,000$7,301,0001.14%
Granite Point Capital Management, L.P. 567,895$5,026,0000.49%
View complete list of STRONGBRIDGE BIOPHARMA PLC shareholders